Overexpression of chaperonin containing TCP1, subunit 3 predicts poor prognosis in hepatocellular carcinoma

Table 1 Clinicopathological features of 104 patients with hepatocellular carcinoma

Characteristics	n (%)
Gender (female/male)	21 (20.2)/83 (79.8)
Age, mean (yr)	58.7 (range 35-84, SD 11.2)
Hepatitis type
HBV	85 (81.7)
HCV	6 (5.8)
None	13 (12.5)
pT category (UICC)
pT1	78 (75)
pT2	14 (13.5)
pT3a	8 (7.7)
pT3b	4 (3.8)
PT4	0 (0.0)
pN category
pN0	104 (100.0)
pN1	0 (0.0)
pM category
pM0	104 (100.0)
pM1	0 (0.0)
UICC stage
I	64 (61.5)
II	12 (11.5)
IIIA	13 (12.5)
IIIB	7 (6.7)
IIIC	8 (7.7)
IV	0 (0.0)
Histological type
Well-differentiated	26 (25.0)
Moderately-differentiated	60 (57.7)
Poorly-differentiated	18 (17.3)
Macrovascular invasion
None	99 (95.2)
Present	5 (4.8)
Microvascular invasion
None	78 (75.0)
Present	26 (25.0)
Tumor size (cm)
≥ 5	58 (55.8)
< 5	46 (44.2)
Serum AFP level (ng/mL)
< 400	79 (76.0)
≥ 400	25 (24.0)
Liver encapsulation invasion
None	93 (89.4)
Present	11 (10.6)
Tumor number
Solitary	83 (79.8)
Multiple	21 (20.2)
Surgical intervention
Radical resection	85 (81.7)
Palliative resection	19 (18.3)
Post-operative TACE
No	22 (21.2)
Yes	82 (78.8)
Child-Pugh classification
A	92 (88.5)
B	12 (11.5)
C	0 (0.0)

HBV: Hepatitis B virus; HCV: Hepatitis C virus; TACE: Transcatheter arterial chemoembolization.